CNC - Public offerings

-- First Quarter GAAP Diluted Earnings Per Share of $3.11; Adjusted Diluted Earnings Per Share of $3.37 ---- Increases 2026 GAAP Diluted EPS Guidance to Greater than $2.37 & Adjusted Diluted EPS to Greater than $3.40 --Strong first quarter 2026 adjusted diluted EPS of $3.37, approximately $0.50 better than our expectations.Medicaid HBR of 93.1%, reflecting continued tangible progress managing medical costs coupled with moderate flu.Medicare segment HBR of 84.9%, from outperformance in both Medicare Advantage and PDP.Commercial HBR of 75.3%, slightly above expectations, primarily reflecting higher acuity among Marketplace Silver Tier members prior to anticipated future 2026 net risk adjustmen

Highlights First metallurgical test at Reid delivers highest grade nickel sulphide concentrate yet achieved by Canada NickelOverall nickel recovery of 63% with half of recovered nickel reporting to nickel sulphide concentrate grading 60%Results achieved utilizing existing flowsheet design developed for the Company's Crawford Nickel Sulphide projectTORONTO, March 15, 2023 /PRNewswire/ - Canada Nickel Company Inc. ("Canada Nickel" or the "Company") (TSXV:CNC) (OTCQX:CNIKF) is pleased to announce robust nickel recoveries from the first metallurgical test on a sample from the Reid property. The test utilized the same mineral processing flowsheet designed for the Company's flagship Crawford Nicke

ST. LOUIS, Nov. 3, 2021 /PRNewswire/ -- Centene Corporation (NYSE:CNC) today issued the following statement with regard to Politan Capital Management: Centene's Board of Directors and management team are committed to acting in the best interests of the Company and its shareholders – and deliver substantial, sustainable value.  We welcome constructive ideas to enhance these efforts.  As previously disclosed, Centene has been aggressively implementing a plan to accelerate value creation. The Company is leveraging its full size and scale to drive margin expansion with a target of at least 3.3% adjusted net income margin by 2024. Progress towards these goals is well underway -- during its most

ST. LOUIS, Nov. 3, 2021 /PRNewswire/ -- Centene Corporation (NYSE:CNC) announced today that it has signed a definitive agreement to sell a majority stake in U.S. Medical Management, LLC (USMM) to Rubicon Founders; Valtruis, a WCAS company; Oak HC/FT; and HLM Venture Partners. Centene will retain a minority stake in USMM. "With more than 25 years of experience in home-based care, USMM has outperformed in numerous value-based care initiatives and consistently delivered lower costs, better health outcomes, and higher patient satisfaction ratings," said Sarah London, Vice Chairman of Centene's Board of Directors. "We are confident this transaction will best position USMM to expand its reach and

ST. LOUIS, June 24, 2021 /PRNewswire/ -- Centene Corporation (NYSE:CNC) ("Centene" or the "Company") announced today that it has priced its previously announced underwritten public offering of $1,800,000,000 aggregate principal amount of 2.450% senior notes due 2028 (the "Notes"). The offering is expected to close on or about July 1, 2021, subject to customary closing conditions. Centene intends to use the net proceeds from the offering of the Notes to finance a portion of the cash consideration payable in connection with Centene's previously announced acquisition of Magellan Health Inc. ("Magellan Health" and such proposed acquisition, the "Magellan Acquisition") and to pay related fees an

ST. LOUIS, June 24, 2021 /PRNewswire/ -- Centene Corporation (NYSE:CNC) ("Centene" or the "Company") announced today that it has commenced an underwritten public offering to sell $1,800,000,000 of senior notes due 2028 (the "Notes"), subject to market and other conditions. Centene intends to use the net proceeds from the offering of the Notes to finance a portion of the cash consideration payable in connection with Centene's previously announced acquisition of Magellan Health Inc. ("Magellan Health" and such proposed acquisition, the "Magellan Acquisition") and to pay related fees and expenses. The closing of the offering is not conditioned on the closing of the Magellan Acquisition. If the

ST. LOUIS, Feb. 18, 2021 /PRNewswire/ -- Centene Corporation (NYSE: CNC) ("Centene" or the "Company") announced the results of its previously announced tender offer (the "Tender Offer") to purchase for cash any and all of its outstanding $2,200,000,000 aggregate principal amount of 4.75% Senior Notes due 2025 (the "2025 Notes") from each registered holder of the 2025 Notes (the "Holders"), which expired as of 5:00 p.m., New York City time, on February 17, 2021 (the "Expiration Time"). The Tender Offer was made pursuant to an Offer to Purchase, dated February 10, 2021 (the "Offer to Purchase"), and the related letter of transmittal and notice of guaranteed delivery for the Tender Offer (toget

ST. LOUIS, Feb. 10, 2021 /PRNewswire/ -- Centene Corporation (NYSE: CNC) ("Centene" or the "Company") announced today that it has priced its previously announced underwritten public offering of $2,200,000,000 aggregate principal amount of 2.50% senior notes due 2031 (the "Notes"). The offering is expected to close on or about February 17, 2021, subject to customary closing conditions. Centene intends to use the net proceeds from the offering of the Notes, together with cash on hand, to (1) fund the purchase price for the Company's 4.75% Senior Notes due 2025 (the "2025 Notes") accepted for purchase by the Company in its concurrent cash tender offer (the "Tender Offer") for any and all $2

ST. LOUIS, Feb. 10, 2021 /PRNewswire/ -- Centene Corporation (NYSE: CNC) ("Centene" or the "Company") announced today that it has commenced an underwritten public offering to sell $2,200,000,000 of senior notes due 2031 (the "Notes"), subject to market and other conditions. Centene intends to use the net proceeds from the offering of the Notes, together with cash on hand, to (1) fund the purchase price for the Company's 4.75% Senior Notes due 2025 (the "2025 Notes") accepted for purchase by the Company in its concurrent cash tender offer (the "Tender Offer") for any and all $2,200,000,000 outstanding aggregate principal amount of the 2025 Notes, (2) redeem any remaining 2025 Notes not val